Literature DB >> 6198003

Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.

S Chousterman, M Chousterman, P Reinert, M N Thang.   

Abstract

The 2'5' oligoadenylate synthetase (2'5' A synthetase) is one of the interferon-induced enzymes. The measurement of its activity may thus reveal the presence of interferon, which is one of the body's non-specific antiviral, antitumor, and immunoregulatory agents. We found a constant level of this enzyme activity (mean value: 0.31 units +/- 0.13 S. D.) when measured in the white blood cells of healthy subjects (104). The majority of the patients with viral (27/30), bacterial (13/16) and autoimmune (15/16) diseases showed a 2'5' A synthetase activity greater than 0.57 units (mean value of the control + S. D.). Conversely the 2'5' A synthetase activity level was normal or low in malignancies and in diseases depending on other aetiologies than those described above. Therefore this simple an rapid biochemical assay seems to be useful for clinical study of infectious and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6198003

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.

Authors:  E C Short; R W Fulton
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

2.  Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.

Authors:  Shuang Ye; Qiang Guo; Jiang-Ping Tang; Cheng-de Yang; Nan Shen; Shun-le Chen
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 2.980

3.  Detection of elevated levels of 2-5A synthetase in serum from children with various infectious diseases.

Authors:  H Sugino; I Mitani; M Koike; T Kodama; J Sokawa; H Sawai; K Ishibashi; M Itoh; S Watanabe; Y Sokawa
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

4.  Serum levels of interferon-alpha and -gamma in acute and chronic hepatitis B virus infection.

Authors:  C M Chu; I S Sheen; C T Yeh; S Y Hsieh; S L Tsai; Y F Liaw
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

5.  2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.

Authors:  W Hylton; J Cayley; C Dore; A M Denman
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103

6.  Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity.

Authors:  M Shindo; A Iwata; T Okuno; M Matsumoto; M Takeda; K Arai; Y Sokawa
Journal:  Gastroenterol Jpn       Date:  1989-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.